An introduction to bone tissue engineering
Standard
An introduction to bone tissue engineering. / Perić Kačarević, Željka; Rider, Patrick; Alkildani, Said; Retnasingh, Sujith; Pejakić, Marija; Schnettler, Reinhard; Gosau, Martin; Smeets, Ralf; Jung, Ole; Barbeck, Mike.
In: INT J ARTIF ORGANS, Vol. 43, No. 2, 02.2020, p. 69-86.Research output: SCORING: Contribution to journal › SCORING: Review article › Research
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - An introduction to bone tissue engineering
AU - Perić Kačarević, Željka
AU - Rider, Patrick
AU - Alkildani, Said
AU - Retnasingh, Sujith
AU - Pejakić, Marija
AU - Schnettler, Reinhard
AU - Gosau, Martin
AU - Smeets, Ralf
AU - Jung, Ole
AU - Barbeck, Mike
PY - 2020/2
Y1 - 2020/2
N2 - Bone tissue has the capability to regenerate itself; however, defects of a critical size prevent the bone from regenerating and require additional support. To aid regeneration, bone scaffolds created out of autologous or allograft bone can be used, yet these produce problems such as fast degradation rates, reduced bioactivity, donor site morbidity or the risk of pathogen transmission. The development of bone tissue engineering has been used to create functional alternatives to regenerate bone. This can be achieved by producing bone tissue scaffolds that induce osteoconduction and integration, provide mechanical stability, and either integrate into the bone structure or degrade and are excreted by the body. A range of different biomaterials have been used to this end, each with their own advantages and disadvantages. This review will introduce the requirements of bone tissue engineering, beginning with the regeneration process of bone before exploring the requirements of bone tissue scaffolds. Aspects covered include the manufacturing process as well as the different materials used and the incorporation of bioactive molecules, growth factors and cells.
AB - Bone tissue has the capability to regenerate itself; however, defects of a critical size prevent the bone from regenerating and require additional support. To aid regeneration, bone scaffolds created out of autologous or allograft bone can be used, yet these produce problems such as fast degradation rates, reduced bioactivity, donor site morbidity or the risk of pathogen transmission. The development of bone tissue engineering has been used to create functional alternatives to regenerate bone. This can be achieved by producing bone tissue scaffolds that induce osteoconduction and integration, provide mechanical stability, and either integrate into the bone structure or degrade and are excreted by the body. A range of different biomaterials have been used to this end, each with their own advantages and disadvantages. This review will introduce the requirements of bone tissue engineering, beginning with the regeneration process of bone before exploring the requirements of bone tissue scaffolds. Aspects covered include the manufacturing process as well as the different materials used and the incorporation of bioactive molecules, growth factors and cells.
KW - Biocompatible Materials/classification
KW - Bone Regeneration/physiology
KW - Humans
KW - Osseointegration/physiology
KW - Tissue Engineering/methods
KW - Tissue Scaffolds
U2 - 10.1177/0391398819876286
DO - 10.1177/0391398819876286
M3 - SCORING: Review article
C2 - 31544576
VL - 43
SP - 69
EP - 86
JO - INT J ARTIF ORGANS
JF - INT J ARTIF ORGANS
SN - 0391-3988
IS - 2
ER -